Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tight Junctions | 19 | 2022 | 149 | 4.390 |
Why?
|
Intestinal Mucosa | 22 | 2021 | 797 | 1.770 |
Why?
|
Sodium-Calcium Exchanger | 11 | 2013 | 19 | 1.580 |
Why?
|
Calcium | 16 | 2024 | 1156 | 1.540 |
Why?
|
Zonula Occludens-1 Protein | 8 | 2020 | 70 | 1.450 |
Why?
|
Epithelial Cells | 11 | 2018 | 669 | 1.440 |
Why?
|
Claudins | 9 | 2022 | 33 | 1.350 |
Why?
|
Colitis, Ulcerative | 12 | 2022 | 711 | 1.240 |
Why?
|
Occludin | 8 | 2020 | 66 | 1.190 |
Why?
|
Claudin-2 | 2 | 2017 | 10 | 1.160 |
Why?
|
Crohn Disease | 7 | 2022 | 730 | 1.030 |
Why?
|
Membrane Proteins | 12 | 2014 | 1196 | 0.980 |
Why?
|
T-Box Domain Proteins | 3 | 2019 | 118 | 0.900 |
Why?
|
Atrial Fibrillation | 4 | 2024 | 288 | 0.870 |
Why?
|
Colon | 13 | 2022 | 496 | 0.850 |
Why?
|
Inflammatory Bowel Diseases | 8 | 2023 | 549 | 0.810 |
Why?
|
Colonic Pouches | 3 | 2022 | 67 | 0.780 |
Why?
|
Colitis | 8 | 2018 | 239 | 0.770 |
Why?
|
Heart Rate | 2 | 2020 | 492 | 0.740 |
Why?
|
Atrioventricular Node | 1 | 2020 | 33 | 0.730 |
Why?
|
Colonic Neoplasms | 9 | 2016 | 556 | 0.730 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2 | 2019 | 21 | 0.710 |
Why?
|
Mutant Proteins | 2 | 2019 | 94 | 0.700 |
Why?
|
Ion Channels | 2 | 2020 | 246 | 0.700 |
Why?
|
Tumor Necrosis Factor-alpha | 6 | 2018 | 683 | 0.700 |
Why?
|
Myocytes, Cardiac | 6 | 2020 | 275 | 0.670 |
Why?
|
Epithelium | 4 | 2020 | 319 | 0.670 |
Why?
|
Mice | 36 | 2024 | 11352 | 0.630 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2020 | 165 | 0.620 |
Why?
|
Sodium | 7 | 2013 | 341 | 0.610 |
Why?
|
Animals | 49 | 2024 | 26582 | 0.580 |
Why?
|
Organoids | 3 | 2022 | 61 | 0.560 |
Why?
|
Biological Transport | 2 | 2015 | 396 | 0.560 |
Why?
|
Myosin-Light-Chain Kinase | 3 | 2010 | 41 | 0.530 |
Why?
|
Muscle Cells | 3 | 2002 | 18 | 0.500 |
Why?
|
Forkhead Transcription Factors | 6 | 2021 | 166 | 0.490 |
Why?
|
Mice, Inbred C57BL | 19 | 2023 | 3092 | 0.480 |
Why?
|
Gastric Mucosa | 1 | 2013 | 66 | 0.450 |
Why?
|
Inflammation | 8 | 2023 | 920 | 0.440 |
Why?
|
Heart Failure | 6 | 2024 | 1204 | 0.430 |
Why?
|
Humans | 64 | 2024 | 86643 | 0.420 |
Why?
|
Cell Proliferation | 7 | 2021 | 1578 | 0.420 |
Why?
|
Myocardium | 4 | 2002 | 529 | 0.410 |
Why?
|
Adenoma | 2 | 2016 | 235 | 0.400 |
Why?
|
Permeability | 7 | 2021 | 137 | 0.400 |
Why?
|
Patch-Clamp Techniques | 6 | 2017 | 396 | 0.390 |
Why?
|
Adenocarcinoma | 5 | 2019 | 1169 | 0.370 |
Why?
|
Cholangitis, Sclerosing | 2 | 2023 | 52 | 0.370 |
Why?
|
Sarcoplasmic Reticulum | 6 | 2019 | 24 | 0.370 |
Why?
|
Interleukin-13 | 1 | 2010 | 36 | 0.360 |
Why?
|
Proctocolectomy, Restorative | 3 | 2022 | 87 | 0.360 |
Why?
|
Dogs | 4 | 2017 | 685 | 0.330 |
Why?
|
Tight Junction Proteins | 2 | 2020 | 14 | 0.320 |
Why?
|
Caco-2 Cells | 6 | 2018 | 123 | 0.320 |
Why?
|
Colorectal Neoplasms | 4 | 2023 | 938 | 0.320 |
Why?
|
Signal Transduction | 9 | 2022 | 3241 | 0.310 |
Why?
|
Interleukin-10 | 4 | 2016 | 149 | 0.310 |
Why?
|
Gene Regulatory Networks | 3 | 2024 | 296 | 0.300 |
Why?
|
Disease Models, Animal | 10 | 2021 | 2232 | 0.290 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 2 | 2020 | 223 | 0.280 |
Why?
|
Cell Membrane | 4 | 2008 | 666 | 0.270 |
Why?
|
Action Potentials | 5 | 2003 | 573 | 0.270 |
Why?
|
Dysbiosis | 2 | 2016 | 70 | 0.270 |
Why?
|
Intestines | 4 | 2020 | 411 | 0.270 |
Why?
|
Myocardial Contraction | 7 | 2016 | 244 | 0.260 |
Why?
|
beta Catenin | 3 | 2014 | 251 | 0.260 |
Why?
|
Models, Biological | 7 | 2017 | 1749 | 0.260 |
Why?
|
Male | 21 | 2021 | 40965 | 0.250 |
Why?
|
Atrial Remodeling | 1 | 2024 | 17 | 0.240 |
Why?
|
Cell Membrane Permeability | 2 | 2018 | 119 | 0.230 |
Why?
|
Cell Line | 6 | 2015 | 2468 | 0.230 |
Why?
|
Cysteine Endopeptidases | 2 | 2014 | 87 | 0.230 |
Why?
|
Kinetics | 4 | 2017 | 1513 | 0.230 |
Why?
|
Homeostasis | 4 | 2020 | 409 | 0.220 |
Why?
|
Endocytosis | 3 | 2013 | 177 | 0.220 |
Why?
|
Transcription Factors | 3 | 2024 | 1565 | 0.220 |
Why?
|
Ventricular Function | 1 | 2002 | 53 | 0.220 |
Why?
|
Calcium Signaling | 3 | 2019 | 129 | 0.220 |
Why?
|
Antibodies, Monoclonal, Humanized | 2 | 2018 | 930 | 0.220 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2022 | 28 | 0.220 |
Why?
|
Ion Transport | 4 | 2010 | 81 | 0.220 |
Why?
|
Wnt Signaling Pathway | 2 | 2021 | 91 | 0.210 |
Why?
|
Claudin-4 | 2 | 2020 | 6 | 0.210 |
Why?
|
Kynurenine | 2 | 2020 | 20 | 0.210 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2021 | 1 | 0.210 |
Why?
|
Salivary Gland Neoplasms | 1 | 2022 | 66 | 0.210 |
Why?
|
Tryptophan | 2 | 2020 | 90 | 0.200 |
Why?
|
Female | 20 | 2021 | 44532 | 0.200 |
Why?
|
Epidermal Growth Factor | 2 | 2012 | 119 | 0.200 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2014 | 379 | 0.200 |
Why?
|
Helicobacter Infections | 1 | 2021 | 34 | 0.200 |
Why?
|
Gastritis | 1 | 2021 | 32 | 0.190 |
Why?
|
Helicobacter pylori | 1 | 2021 | 35 | 0.190 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2001 | 45 | 0.190 |
Why?
|
Cellular Reprogramming | 1 | 2021 | 37 | 0.190 |
Why?
|
Aged | 12 | 2021 | 18415 | 0.190 |
Why?
|
Severity of Illness Index | 4 | 2020 | 1801 | 0.190 |
Why?
|
Plasma Cells | 1 | 2021 | 80 | 0.190 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2020 | 78 | 0.190 |
Why?
|
Cells, Cultured | 3 | 2021 | 2818 | 0.190 |
Why?
|
Biomarkers, Tumor | 4 | 2016 | 1464 | 0.190 |
Why?
|
Stomach | 1 | 2021 | 108 | 0.190 |
Why?
|
Mice, Knockout | 9 | 2021 | 1924 | 0.190 |
Why?
|
Lifting | 1 | 2020 | 12 | 0.190 |
Why?
|
Diet | 1 | 2023 | 443 | 0.190 |
Why?
|
Citrobacter rodentium | 2 | 2011 | 13 | 0.190 |
Why?
|
Mice, Transgenic | 6 | 2021 | 1540 | 0.190 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2021 | 295 | 0.190 |
Why?
|
Endoscopic Mucosal Resection | 1 | 2020 | 21 | 0.180 |
Why?
|
Microfluidics | 1 | 2020 | 51 | 0.180 |
Why?
|
Lymphocyte Activation | 2 | 2021 | 728 | 0.180 |
Why?
|
Middle Aged | 13 | 2021 | 25028 | 0.180 |
Why?
|
Alveolar Epithelial Cells | 1 | 2020 | 18 | 0.180 |
Why?
|
Myosin Heavy Chains | 1 | 2020 | 88 | 0.180 |
Why?
|
Carcinogenesis | 2 | 2019 | 195 | 0.180 |
Why?
|
Connexin 43 | 1 | 2020 | 94 | 0.180 |
Why?
|
Antineoplastic Agents | 3 | 2020 | 2360 | 0.180 |
Why?
|
Polyethylene Glycols | 2 | 2012 | 363 | 0.180 |
Why?
|
Respiratory Mucosa | 1 | 2020 | 88 | 0.170 |
Why?
|
Cations, Divalent | 1 | 2019 | 39 | 0.170 |
Why?
|
Potassium Channels, Voltage-Gated | 1 | 2020 | 122 | 0.170 |
Why?
|
Serotonin | 1 | 2020 | 218 | 0.170 |
Why?
|
Phosphatidylinositol 3-Kinases | 5 | 2011 | 262 | 0.170 |
Why?
|
Phosphoproteins | 5 | 2012 | 254 | 0.170 |
Why?
|
Actins | 3 | 2015 | 451 | 0.170 |
Why?
|
KRIT1 Protein | 1 | 2018 | 62 | 0.170 |
Why?
|
Connexins | 1 | 2020 | 200 | 0.170 |
Why?
|
Janus Kinases | 1 | 2018 | 23 | 0.160 |
Why?
|
Myosin Type II | 1 | 2018 | 50 | 0.160 |
Why?
|
Genetic Loci | 1 | 2019 | 250 | 0.160 |
Why?
|
Allosteric Regulation | 3 | 2003 | 68 | 0.160 |
Why?
|
Janus Kinase Inhibitors | 1 | 2018 | 19 | 0.160 |
Why?
|
Bacterial Physiological Phenomena | 1 | 2018 | 40 | 0.160 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 41 | 0.160 |
Why?
|
Computer Simulation | 3 | 2017 | 1078 | 0.160 |
Why?
|
Mixed Tumor, Malignant | 1 | 2017 | 3 | 0.160 |
Why?
|
Carcinoma, Acinar Cell | 1 | 2017 | 11 | 0.160 |
Why?
|
Calcineurin Inhibitors | 1 | 2018 | 54 | 0.160 |
Why?
|
RNA, Untranslated | 1 | 2017 | 63 | 0.150 |
Why?
|
Madin Darby Canine Kidney Cells | 1 | 2017 | 18 | 0.150 |
Why?
|
Wound Healing | 2 | 2018 | 344 | 0.150 |
Why?
|
rho-Associated Kinases | 1 | 2018 | 159 | 0.150 |
Why?
|
Pyrazoles | 1 | 2018 | 153 | 0.150 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 479 | 0.150 |
Why?
|
Pouchitis | 1 | 2017 | 44 | 0.140 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2015 | 243 | 0.140 |
Why?
|
RNA, Small Interfering | 4 | 2012 | 547 | 0.140 |
Why?
|
Protein Binding | 4 | 2013 | 1456 | 0.140 |
Why?
|
Butyrates | 1 | 2016 | 42 | 0.140 |
Why?
|
Pancreatic Neoplasms | 2 | 2020 | 645 | 0.140 |
Why?
|
Gastrointestinal Agents | 1 | 2018 | 161 | 0.140 |
Why?
|
Gastrointestinal Motility | 1 | 2016 | 25 | 0.140 |
Why?
|
Lymphocytes | 1 | 2018 | 464 | 0.140 |
Why?
|
Dextran Sulfate | 2 | 2015 | 68 | 0.140 |
Why?
|
Protein Structure, Tertiary | 3 | 2013 | 736 | 0.140 |
Why?
|
Rabbits | 4 | 2013 | 636 | 0.140 |
Why?
|
Interleukin-15 | 1 | 2016 | 72 | 0.140 |
Why?
|
Leukemia | 1 | 2018 | 320 | 0.140 |
Why?
|
Neuroendocrine Tumors | 1 | 2017 | 105 | 0.140 |
Why?
|
Sequence Deletion | 2 | 2013 | 205 | 0.140 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 894 | 0.140 |
Why?
|
Foundations | 1 | 2015 | 25 | 0.140 |
Why?
|
Physiology | 1 | 2015 | 16 | 0.140 |
Why?
|
Enhancer Elements, Genetic | 1 | 2017 | 266 | 0.130 |
Why?
|
Toll-Like Receptor 4 | 1 | 2016 | 88 | 0.130 |
Why?
|
Gene Knockdown Techniques | 2 | 2013 | 236 | 0.130 |
Why?
|
Peptide Hormones | 1 | 2015 | 29 | 0.130 |
Why?
|
Spectrum Analysis | 1 | 2015 | 118 | 0.130 |
Why?
|
Claudin-1 | 3 | 2011 | 17 | 0.130 |
Why?
|
In Vitro Techniques | 4 | 2021 | 989 | 0.130 |
Why?
|
Immunity, Innate | 1 | 2018 | 409 | 0.130 |
Why?
|
Stomach Neoplasms | 1 | 2017 | 266 | 0.130 |
Why?
|
Ion Channel Gating | 1 | 2017 | 324 | 0.120 |
Why?
|
Proto-Oncogene Proteins | 1 | 2018 | 645 | 0.120 |
Why?
|
Aspirin | 1 | 2015 | 156 | 0.120 |
Why?
|
DNA-Binding Proteins | 2 | 2018 | 1208 | 0.120 |
Why?
|
Cell Line, Tumor | 7 | 2015 | 2426 | 0.120 |
Why?
|
Forkhead Box Protein O3 | 5 | 2013 | 20 | 0.120 |
Why?
|
Caveolin 1 | 2 | 2013 | 20 | 0.120 |
Why?
|
Cell Separation | 3 | 2003 | 196 | 0.120 |
Why?
|
Interferon Type I | 1 | 2015 | 175 | 0.120 |
Why?
|
Apoptosis | 2 | 2018 | 1683 | 0.120 |
Why?
|
Leiomyosarcoma | 1 | 2014 | 40 | 0.120 |
Why?
|
Cytokines | 4 | 2021 | 776 | 0.120 |
Why?
|
Lung | 1 | 2020 | 1170 | 0.120 |
Why?
|
Young Adult | 6 | 2021 | 5976 | 0.120 |
Why?
|
Down-Regulation | 5 | 2013 | 504 | 0.120 |
Why?
|
Bifidobacterium | 1 | 2013 | 16 | 0.110 |
Why?
|
Phosphorylation | 5 | 2018 | 1106 | 0.110 |
Why?
|
Inflammation Mediators | 1 | 2014 | 154 | 0.110 |
Why?
|
Rectal Neoplasms | 1 | 2014 | 116 | 0.110 |
Why?
|
Transcription, Genetic | 1 | 2017 | 1135 | 0.110 |
Why?
|
Capsaicin | 1 | 2012 | 44 | 0.110 |
Why?
|
TRPV Cation Channels | 1 | 2012 | 15 | 0.110 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2014 | 123 | 0.110 |
Why?
|
Sodium-Potassium-Chloride Symporters | 1 | 2012 | 22 | 0.110 |
Why?
|
Adolescent | 6 | 2021 | 8981 | 0.110 |
Why?
|
Bacteria | 1 | 2016 | 447 | 0.110 |
Why?
|
Adult | 10 | 2021 | 25648 | 0.110 |
Why?
|
Microbiota | 2 | 2016 | 381 | 0.110 |
Why?
|
Trinitrobenzenesulfonic Acid | 1 | 2012 | 16 | 0.110 |
Why?
|
Homeodomain Proteins | 1 | 2016 | 536 | 0.110 |
Why?
|
Up-Regulation | 3 | 2013 | 712 | 0.110 |
Why?
|
Transcriptome | 1 | 2017 | 580 | 0.110 |
Why?
|
Chlorides | 1 | 2012 | 103 | 0.110 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2012 | 47 | 0.110 |
Why?
|
Klebsiella Infections | 1 | 2012 | 25 | 0.110 |
Why?
|
Klebsiella pneumoniae | 1 | 2012 | 34 | 0.100 |
Why?
|
Lipopolysaccharides | 2 | 2015 | 286 | 0.100 |
Why?
|
Opportunistic Infections | 1 | 2012 | 59 | 0.100 |
Why?
|
Interleukin-8 | 2 | 2009 | 86 | 0.100 |
Why?
|
Lipid Metabolism | 1 | 2013 | 196 | 0.100 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2013 | 78 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2021 | 1197 | 0.100 |
Why?
|
Nuclear Proteins | 1 | 2016 | 696 | 0.100 |
Why?
|
Neoplasm Proteins | 2 | 2013 | 532 | 0.100 |
Why?
|
Genistein | 1 | 2011 | 16 | 0.100 |
Why?
|
Enterobacteriaceae Infections | 1 | 2011 | 23 | 0.100 |
Why?
|
Molecular Structure | 1 | 2012 | 287 | 0.100 |
Why?
|
Bacterial Adhesion | 1 | 2011 | 84 | 0.100 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2012 | 102 | 0.100 |
Why?
|
Carrier Proteins | 1 | 2015 | 673 | 0.100 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2021 | 2357 | 0.100 |
Why?
|
ErbB Receptors | 2 | 2012 | 485 | 0.100 |
Why?
|
Electric Conductivity | 3 | 2012 | 144 | 0.100 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2014 | 425 | 0.100 |
Why?
|
Aged, 80 and over | 4 | 2021 | 6509 | 0.100 |
Why?
|
Cytosol | 3 | 2010 | 189 | 0.090 |
Why?
|
Heart Ventricles | 4 | 2003 | 760 | 0.090 |
Why?
|
Heart Atria | 2 | 2024 | 250 | 0.090 |
Why?
|
Gastrointestinal Microbiome | 1 | 2016 | 455 | 0.090 |
Why?
|
Mouth Neoplasms | 1 | 2012 | 194 | 0.090 |
Why?
|
T-Lymphocyte Subsets | 1 | 2012 | 272 | 0.090 |
Why?
|
Electrophysiology | 3 | 2011 | 401 | 0.090 |
Why?
|
Biopsy | 3 | 2021 | 1163 | 0.090 |
Why?
|
Molecular Targeted Therapy | 1 | 2012 | 266 | 0.090 |
Why?
|
Microscopy, Electron | 2 | 2022 | 503 | 0.090 |
Why?
|
Tissue Culture Techniques | 1 | 2010 | 79 | 0.090 |
Why?
|
Protein Transport | 4 | 2013 | 411 | 0.090 |
Why?
|
Cell Movement | 2 | 2012 | 758 | 0.090 |
Why?
|
Receptors, Retinoic Acid | 1 | 2009 | 45 | 0.080 |
Why?
|
Algorithms | 1 | 2017 | 1830 | 0.080 |
Why?
|
Biomarkers | 3 | 2021 | 1718 | 0.080 |
Why?
|
Prospective Studies | 4 | 2018 | 4213 | 0.080 |
Why?
|
Enzyme Activation | 1 | 2010 | 692 | 0.080 |
Why?
|
C-Reactive Protein | 2 | 2020 | 190 | 0.080 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 2 | 2021 | 19 | 0.080 |
Why?
|
T Cell Transcription Factor 1 | 2 | 2021 | 23 | 0.080 |
Why?
|
Recombinant Proteins | 1 | 2010 | 1014 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 3 | 2013 | 36 | 0.080 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 2 | 2021 | 80 | 0.080 |
Why?
|
Stem Cells | 1 | 2010 | 351 | 0.080 |
Why?
|
Matrix Metalloproteinases, Membrane-Associated | 1 | 2007 | 4 | 0.080 |
Why?
|
Cytoskeleton | 1 | 2009 | 193 | 0.080 |
Why?
|
Genome-Wide Association Study | 3 | 2021 | 1621 | 0.080 |
Why?
|
Germ-Free Life | 2 | 2018 | 69 | 0.080 |
Why?
|
Calcium-Transporting ATPases | 3 | 2003 | 29 | 0.070 |
Why?
|
Shab Potassium Channels | 1 | 2006 | 29 | 0.070 |
Why?
|
Arachidonic Acid | 1 | 2006 | 63 | 0.070 |
Why?
|
Membrane Potentials | 3 | 2002 | 435 | 0.070 |
Why?
|
Base Sequence | 1 | 2010 | 2330 | 0.070 |
Why?
|
HT29 Cells | 3 | 2011 | 49 | 0.070 |
Why?
|
Endoscopy | 2 | 2020 | 332 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2018 | 999 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2011 | 322 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2021 | 1805 | 0.060 |
Why?
|
Phenotype | 2 | 2022 | 2378 | 0.060 |
Why?
|
Nickel | 2 | 2002 | 13 | 0.060 |
Why?
|
Interferon-gamma | 1 | 2007 | 444 | 0.060 |
Why?
|
Logistic Models | 2 | 2018 | 1186 | 0.060 |
Why?
|
GATA4 Transcription Factor | 1 | 2024 | 17 | 0.060 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2023 | 15 | 0.060 |
Why?
|
RNA, Messenger | 1 | 2010 | 1981 | 0.060 |
Why?
|
Ferrets | 2 | 2001 | 47 | 0.060 |
Why?
|
Tumor Necrosis Factor alpha-Induced Protein 3 | 2 | 2014 | 15 | 0.060 |
Why?
|
Chemoprevention | 2 | 2015 | 91 | 0.060 |
Why?
|
Pancreatitis-Associated Proteins | 2 | 2014 | 15 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2019 | 381 | 0.060 |
Why?
|
Islets of Langerhans | 1 | 2006 | 544 | 0.060 |
Why?
|
Immunohistochemistry | 2 | 2021 | 1753 | 0.060 |
Why?
|
Ions | 1 | 2003 | 74 | 0.060 |
Why?
|
Freeze Fracturing | 1 | 2022 | 12 | 0.060 |
Why?
|
Models, Animal | 2 | 2015 | 263 | 0.060 |
Why?
|
Colonoscopy | 2 | 2018 | 264 | 0.060 |
Why?
|
Retrospective Studies | 3 | 2022 | 8489 | 0.050 |
Why?
|
Intracellular Fluid | 1 | 2002 | 34 | 0.050 |
Why?
|
Ligands | 1 | 2023 | 433 | 0.050 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2022 | 93 | 0.050 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2002 | 78 | 0.050 |
Why?
|
Indoles | 1 | 2023 | 318 | 0.050 |
Why?
|
Receptors, Notch | 1 | 2022 | 120 | 0.050 |
Why?
|
Drug Discovery | 1 | 2022 | 103 | 0.050 |
Why?
|
Cohort Studies | 1 | 2008 | 2767 | 0.050 |
Why?
|
Gastroscopy | 1 | 2021 | 23 | 0.050 |
Why?
|
Blotting, Western | 2 | 2012 | 782 | 0.050 |
Why?
|
Interferon Regulatory Factors | 1 | 2021 | 67 | 0.050 |
Why?
|
Mutagenesis | 1 | 2001 | 199 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2014 | 427 | 0.050 |
Why?
|
Automation | 1 | 2020 | 106 | 0.050 |
Why?
|
Injections | 1 | 2020 | 109 | 0.050 |
Why?
|
MAP Kinase Kinase Kinase 3 | 1 | 2020 | 12 | 0.050 |
Why?
|
Endothelium | 1 | 2020 | 59 | 0.050 |
Why?
|
Ileum | 1 | 2020 | 159 | 0.050 |
Why?
|
Cell Culture Techniques | 1 | 2020 | 188 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 376 | 0.040 |
Why?
|
Cell Cycle | 2 | 2012 | 502 | 0.040 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2020 | 83 | 0.040 |
Why?
|
Binding Sites | 2 | 2014 | 1098 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2022 | 639 | 0.040 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2019 | 40 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2022 | 456 | 0.040 |
Why?
|
Heart | 2 | 2017 | 539 | 0.040 |
Why?
|
Mice, Inbred BALB C | 1 | 2021 | 1047 | 0.040 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2019 | 51 | 0.040 |
Why?
|
Promoter Regions, Genetic | 2 | 2013 | 937 | 0.040 |
Why?
|
Tumor Necrosis Factors | 1 | 2018 | 14 | 0.040 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2018 | 40 | 0.040 |
Why?
|
Lactobacillus | 1 | 2018 | 21 | 0.040 |
Why?
|
Penetrance | 1 | 2018 | 44 | 0.040 |
Why?
|
Thapsigargin | 1 | 1998 | 55 | 0.040 |
Why?
|
Isoproterenol | 1 | 1998 | 59 | 0.040 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 154 | 0.040 |
Why?
|
Genomics | 1 | 2024 | 720 | 0.040 |
Why?
|
Toll-Like Receptor 2 | 1 | 2018 | 33 | 0.040 |
Why?
|
Dioxygenases | 1 | 2018 | 74 | 0.040 |
Why?
|
Acinar Cells | 1 | 2017 | 6 | 0.040 |
Why?
|
Nitriles | 1 | 2018 | 149 | 0.040 |
Why?
|
Metabolic Networks and Pathways | 1 | 2018 | 79 | 0.040 |
Why?
|
Biological Therapy | 1 | 2018 | 45 | 0.040 |
Why?
|
Molecular Dynamics Simulation | 1 | 2020 | 245 | 0.040 |
Why?
|
Cardiotonic Agents | 1 | 1998 | 87 | 0.040 |
Why?
|
Histocytochemistry | 1 | 2017 | 130 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2019 | 526 | 0.040 |
Why?
|
Endoscopy, Digestive System | 1 | 2017 | 65 | 0.040 |
Why?
|
Cyclosporine | 1 | 2018 | 234 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2018 | 315 | 0.040 |
Why?
|
Periodicity | 1 | 2017 | 119 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2018 | 256 | 0.040 |
Why?
|
Atrial Function | 1 | 2016 | 17 | 0.040 |
Why?
|
Anemia | 1 | 2017 | 128 | 0.040 |
Why?
|
Actin Cytoskeleton | 1 | 2018 | 192 | 0.040 |
Why?
|
Tacrolimus | 1 | 2018 | 373 | 0.040 |
Why?
|
Bacterial Infections | 1 | 2018 | 182 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 1673 | 0.040 |
Why?
|
Remission Induction | 1 | 2018 | 722 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 916 | 0.030 |
Why?
|
Fecal Microbiota Transplantation | 1 | 2016 | 62 | 0.030 |
Why?
|
Haploinsufficiency | 1 | 2016 | 62 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 1313 | 0.030 |
Why?
|
Piroxicam | 1 | 2015 | 11 | 0.030 |
Why?
|
Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 199 | 0.030 |
Why?
|
Dinoprostone | 1 | 2015 | 69 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2016 | 193 | 0.030 |
Why?
|
Protective Agents | 1 | 2015 | 33 | 0.030 |
Why?
|
Anniversaries and Special Events | 1 | 2015 | 14 | 0.030 |
Why?
|
Pyrimidines | 1 | 2018 | 370 | 0.030 |
Why?
|
Autophagy-Related Proteins | 1 | 2015 | 21 | 0.030 |
Why?
|
Adoptive Transfer | 1 | 2015 | 168 | 0.030 |
Why?
|
Ultrasonography | 1 | 2017 | 695 | 0.030 |
Why?
|
Feces | 1 | 2016 | 319 | 0.030 |
Why?
|
Rectum | 1 | 2015 | 146 | 0.030 |
Why?
|
Ribonuclease, Pancreatic | 1 | 2014 | 24 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2021 | 2705 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 2014 | 85 | 0.030 |
Why?
|
Glucuronosyltransferase | 1 | 2015 | 184 | 0.030 |
Why?
|
Child, Preschool | 1 | 2021 | 3612 | 0.030 |
Why?
|
Genes, APC | 1 | 2014 | 26 | 0.030 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2014 | 69 | 0.030 |
Why?
|
Chromatin | 1 | 2016 | 380 | 0.030 |
Why?
|
Perilipin-2 | 1 | 2013 | 2 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 1991 | 0.030 |
Why?
|
Th17 Cells | 1 | 2014 | 80 | 0.030 |
Why?
|
Chicago | 1 | 2018 | 1379 | 0.030 |
Why?
|
Enterocytes | 1 | 2013 | 18 | 0.030 |
Why?
|
Gene Deletion | 1 | 2014 | 329 | 0.030 |
Why?
|
Rats | 2 | 2012 | 3990 | 0.030 |
Why?
|
Solute Carrier Family 12, Member 2 | 1 | 2012 | 16 | 0.030 |
Why?
|
Sirtuins | 1 | 2013 | 45 | 0.030 |
Why?
|
Diterpenes | 1 | 2012 | 20 | 0.030 |
Why?
|
Acrylamides | 1 | 2012 | 30 | 0.030 |
Why?
|
Colforsin | 1 | 2012 | 74 | 0.030 |
Why?
|
Biotinylation | 1 | 2012 | 41 | 0.030 |
Why?
|
4-Nitroquinoline-1-oxide | 1 | 2012 | 15 | 0.030 |
Why?
|
Time Factors | 2 | 2012 | 5210 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2014 | 325 | 0.030 |
Why?
|
Mucin-2 | 1 | 2012 | 12 | 0.030 |
Why?
|
Bridged Bicyclo Compounds, Heterocyclic | 1 | 2012 | 76 | 0.030 |
Why?
|
Receptors, Polymeric Immunoglobulin | 1 | 2012 | 5 | 0.030 |
Why?
|
Administration, Topical | 1 | 2012 | 95 | 0.030 |
Why?
|
Rats, Inbred F344 | 1 | 2012 | 156 | 0.030 |
Why?
|
Cyclin D1 | 1 | 2012 | 83 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 74 | 0.030 |
Why?
|
Mouth Mucosa | 1 | 2012 | 67 | 0.030 |
Why?
|
Incidence | 1 | 2016 | 1577 | 0.030 |
Why?
|
Immunity, Mucosal | 1 | 2012 | 69 | 0.030 |
Why?
|
Integrin beta1 | 1 | 2011 | 33 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2013 | 510 | 0.030 |
Why?
|
Intracellular Space | 1 | 2011 | 38 | 0.030 |
Why?
|
Metagenome | 1 | 2012 | 102 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2012 | 305 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2013 | 227 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2015 | 1823 | 0.020 |
Why?
|
HCT116 Cells | 1 | 2011 | 151 | 0.020 |
Why?
|
Survival Analysis | 1 | 2015 | 1538 | 0.020 |
Why?
|
Dopamine | 1 | 2012 | 275 | 0.020 |
Why?
|
Genotype | 1 | 2015 | 1851 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2011 | 86 | 0.020 |
Why?
|
Administration, Oral | 1 | 2012 | 684 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 879 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2012 | 460 | 0.020 |
Why?
|
Child | 1 | 2021 | 6927 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2010 | 123 | 0.020 |
Why?
|
I-kappa B Kinase | 1 | 2009 | 37 | 0.020 |
Why?
|
Risk Factors | 1 | 2019 | 5417 | 0.020 |
Why?
|
NF-kappa B | 1 | 2012 | 444 | 0.020 |
Why?
|
Gene Silencing | 1 | 2009 | 172 | 0.020 |
Why?
|
Fluorescence Recovery After Photobleaching | 1 | 2008 | 13 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2012 | 1961 | 0.020 |
Why?
|
Diffusion | 1 | 2008 | 93 | 0.020 |
Why?
|
Mutation | 1 | 2019 | 3968 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2015 | 3640 | 0.020 |
Why?
|
Glycosylphosphatidylinositols | 1 | 2007 | 8 | 0.020 |
Why?
|
Disease Progression | 1 | 2012 | 1531 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 2271 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2008 | 95 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2007 | 17 | 0.020 |
Why?
|
Cell Polarity | 1 | 2008 | 115 | 0.020 |
Why?
|
GPI-Linked Proteins | 1 | 2007 | 50 | 0.020 |
Why?
|
Haplorhini | 1 | 2007 | 81 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2007 | 24 | 0.020 |
Why?
|
Carbachol | 1 | 2006 | 34 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2009 | 579 | 0.020 |
Why?
|
Phospholipases A | 1 | 2006 | 45 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2007 | 156 | 0.020 |
Why?
|
Intestine, Small | 1 | 2009 | 303 | 0.020 |
Why?
|
Proteins | 1 | 2012 | 777 | 0.020 |
Why?
|
Infant | 1 | 2013 | 3046 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2007 | 214 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 589 | 0.020 |
Why?
|
Cell Division | 1 | 2007 | 696 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2018 | 7993 | 0.020 |
Why?
|
Transfection | 1 | 2007 | 896 | 0.020 |
Why?
|
Computational Biology | 1 | 2008 | 528 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2010 | 1195 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2007 | 2062 | 0.010 |
Why?
|
Guinea Pigs | 1 | 2002 | 171 | 0.010 |
Why?
|
Strophanthidin | 1 | 2002 | 3 | 0.010 |
Why?
|
Tetrodotoxin | 1 | 2002 | 50 | 0.010 |
Why?
|
Sodium Channel Blockers | 1 | 2002 | 27 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2007 | 3030 | 0.010 |
Why?
|
Diastole | 1 | 2002 | 144 | 0.010 |
Why?
|
Sodium Channels | 1 | 2002 | 129 | 0.010 |
Why?
|
Electric Stimulation | 1 | 2002 | 347 | 0.010 |
Why?
|